Comparative Pharmacology
Head-to-head clinical analysis: CHLOROPTIC S O P versus COR OTICIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROPTIC S O P versus COR OTICIN.
CHLOROPTIC S.O.P. vs COR-OTICIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
COR-OTICIN is a combination product containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit) and polymyxin B (a polymyxin antibiotic that disrupts bacterial cell membrane permeability).
Apply 0.5-inch ribbon into the conjunctival sac(s) 1-2 times daily, or more frequently as directed.
1-2 drops in each affected ear twice daily for 7 days.
None Documented
None Documented
Terminal half-life approximately 4-6 hours; clinical context: dosing every 4-6 hours for ocular infections
Terminal half-life 4-6 hours; prolonged in renal impairment (up to 12-15 hours)
Renal (70-80% as unchanged drug and metabolites), biliary/fecal (20-30%)
Renal (60-80% unchanged), fecal/biliary (5-10%)
Category C
Category C
Antibiotic
Topical Corticosteroid + Antibiotic